A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The main objective of the study will be to evaluate the efficacy of sutetinib maleate
capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC
(uncommon EGFR mutations only).